Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn M Torres

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 27, 2012
Features, diagnosis, and treatment of nonalcoholic fatty liver diseaseDawn M Torres, Christopher D Williams, Stephen A Harrison
Clinical Liver Disease|June 13, 2019
Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exerciseAngelo H Paredes, Dawn M Torres, Stephen A Harrison
Clinics in Liver Disease|May 1, 2012
Nonalcoholic fatty liver diseaseAngelo H Paredes, Dawn M Torres, Stephen A Harrison
Journal of Clinical Gastroenterology|September 4, 2009
Effect of weight loss on nonalcoholic fatty liver diseaseAnish A Patel, Dawn M Torres, Stephen A Harrison
Journal of Clinical Gastroenterology|May 19, 2009
A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trialAustin Nelson, Dawn M Torres, Ana E Morgan, et al.
The American Journal of Gastroenterology|December 7, 2010
Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case seriesPatrick R Kenny, Daniel E Brady, Dawn M Torres, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2009
Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label studyDaniel E Brady, Dawn M Torres, Jong W An, et al.
Hepatology (Baltimore, Md.)|July 13, 2011
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trialDawn M Torres, Frances J Jones, Janet C Shaw, et al.
Therapeutic Advances in Gastroenterology|July 2, 2013
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trialCarly Eckard, Renee Cole, Joshua Lockwood, et al.
Hepatology (Baltimore, Md.)|October 12, 2011
Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosisJeffrey W Molloy, Christopher J Calcagno, Christopher D Williams, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 27, 2012
Features, diagnosis, and treatment of nonalcoholic fatty liver diseaseDawn M Torres, Christopher D Williams, Stephen A Harrison
Clinical Liver Disease|June 13, 2019
Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exerciseAngelo H Paredes, Dawn M Torres, Stephen A Harrison
Clinics in Liver Disease|May 1, 2012
Nonalcoholic fatty liver diseaseAngelo H Paredes, Dawn M Torres, Stephen A Harrison
Journal of Clinical Gastroenterology|September 4, 2009
Effect of weight loss on nonalcoholic fatty liver diseaseAnish A Patel, Dawn M Torres, Stephen A Harrison
Journal of Clinical Gastroenterology|May 19, 2009
A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trialAustin Nelson, Dawn M Torres, Ana E Morgan, et al.
The American Journal of Gastroenterology|December 7, 2010
Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: a case seriesPatrick R Kenny, Daniel E Brady, Dawn M Torres, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2009
Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label studyDaniel E Brady, Dawn M Torres, Jong W An, et al.
Hepatology (Baltimore, Md.)|July 13, 2011
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trialDawn M Torres, Frances J Jones, Janet C Shaw, et al.
Therapeutic Advances in Gastroenterology|July 2, 2013
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trialCarly Eckard, Renee Cole, Joshua Lockwood, et al.
Hepatology (Baltimore, Md.)|October 12, 2011
Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosisJeffrey W Molloy, Christopher J Calcagno, Christopher D Williams, et al.
Pageof 4